- Push-out Score determined
- After about two years in the position
- Brandon Sim taking over
- Kenneth Sim will remain as Executive Chairman at Apollo Medical
- Kenneth Sim spoke at length and said 142 words
(exechange) — Alhambra, California, November 4, 2021 — Kenneth Sim, co-chief executive of Apollo Medical, leaves his position. As announced by Apollo Medical Holdings Inc. in a news release and in a regulatory filing published on Thursday, November 4, 2021, Kenneth Sim has left his post as co-chief executive officer at the healthcare company, after about two years in the role, effective November 2, 2021.
Kenneth Sim’s duties as Co-CEO will be taken over by Brandon Sim, most recently Chief Operating Officer at Apollo Medical Holdings Inc.
It is a generational change as well. Brandon Sim is about 39 years younger than Kenneth Sim.
Brandon Sim is the son of Kenneth Sim.
“A natural progression”
Apollo Medical did not give an explicit reason for Kenneth Sim’s departure from the Co-CEO post. Thomas S. Lam, Co-Chief Executive Officer, President, and Director of ApolloMed, said: “We are pleased to appoint Brandon Co-CEO of ApolloMed, which we felt was a natural progression given his ongoing leadership in critical areas of our business that have driven phenomenal results for the Company over the past couple of years.”
Kenneth Sim will remain as Executive Chairman at Apollo Medical
“Apollo Medical Holdings, Inc. (“ApolloMed,” and together with its subsidiaries and affiliated entities, the “Company”) (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced the appointment of Brandon Sim to the role of Co-Chief Executive Officer (“Co-CEO”), effective November 2, 2021. With this appointment, Kenneth Sim, M.D. will no longer serve as Co-CEO of ApolloMed but will continue in his role as Executive Chairman,” Apollo Medical said.
Apollo Medical said: “In connection with Brandon Sim’s appointment, Kenneth Sim, M.D. will step out of his current role as Co-Chief Executive Officer. He will continue to serve as the Company’s Executive Chairman.”
Share price increase since November 2020
The announcement follows an increase in Apollo Medical Holdings Inc.’s share price of 327% since November 2020.
In the position of CEO since 2019
Kenneth Sim became Co-CEO of the Company in 2019.
Kenneth Sim has served as Executive Chairman of the Board since December 2017 and as Co-Chief Executive Officer of the Company since September 2019.
He has also served as a member of NMM’s board of directors from 2006 to 2013, as Chairman of NMM’s board of directors since 2013 and as Chairman of APC’s board of directors since 2014.
Kenneth Sim is a Fellow of the American College of Surgeons and was awarded the Independent Physician Leadership Award in 2014 by the Los Angeles County Medical Association.
He was recognized by the Chinese-American Elected Officials community organization as a recipient of its 2020 Lifetime Achievement Award.
Kenneth Sim is a member of the Governing Board of Directors at Alhambra Hospital Medical Center and the Chief of Surgery at Garfield Medical Center.
He serves on the board of directors of the National Council of Asian Pacific Islander Physicians and the OneLegacy Foundation.
As an entrepreneur, Kenneth Sim founded Healthcare Cities in Arcadia, City of Industry, and Downtown Los Angeles in California, which helped streamline the healthcare process by providing outpatient health services at one location, including a surgical center, senior wellness center, laboratory, radiology and urgent care.
He received his bachelor’s degree from the University of California, Los Angeles (“UCLA”) and received his medical training from the Loma Linda University School of Medicine and the Autonomous University of Guadalajara in Guadalajara, Mexico.
Push-out Score determined
The Push-out Score™ determined by exechange gauges the pressure surrounding Kenneth Sim’s move on a scale of 0 to 10.
exechange reached out to Apollo Medical and offered the company the opportunity to comment on the score.
Read the full story in the exechange report 45.2021 ($).